Glucuronidation of dihydrocodeine by human liver microsomes and the effect of inhibitors

Lynette C. Kirkwood, Roger L. Nation, Andrew A. Somogyi

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Abstract

1. Glucuronidation is the major route of metabolism of dihydrocodeine (DHC) and accounts for 25-30% of an oral dose in urine. The kinetics of DHC-6-glucuronide formation in liver microsomes from five human donors and the effect of a number of potential inhibitor drugs were examined using a newly developed and validated HPLC assay. 2. The formation of DHC-6-glucuronide exhibited atypical kinetics that conformed to the Hill equation. The mean intrinsic dissociation constant (K(s)) and maximum velocity (V(max)) values were 1566 μmol/L and 0.043 μmol/min per g, respectively. The K(s) and V(max) values varied 1.5- and 3.5-fold, respectively. 3. Seven drugs were tested for inhibitory effects on DHC glucuronidation at low (50 μmol/L) and high (500 (μmol/L) concentratioms. At 50 μmol/L, only diclofenac produced greater than 50% inhibition, while at concentrations of 500 μmol/L inhibition was greater than 35% for diclofenac, amitriptyline, oxazepam, naproxen, chloramphenicol and probenecid, but not paracetamol. 4. The present study found little interindividual variation in the activity of human liver microsomes for glucuronidation of DHC. Comparison of the results from the inhibition studies with those reported previously for codeine and morphine suggest that the UDP-glucuronosyltransferase isoform UGT2B7 is involved in the glucuronidation of DHC.

Original languageEnglish
Pages (from-to)266-270
Number of pages5
JournalClinical and Experimental Pharmacology and Physiology
Volume25
Issue number3-4
DOIs
Publication statusPublished - 1 Jan 1998

Keywords

  • Dihydrocodeine
  • Dihydrocodeine-6-glucuronide
  • Glucuronosyltransferase
  • HPLC analysis
  • Human liver microsomes
  • Metabolism

Cite this